tiprankstipranks
EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT
US Market

EyePoint Pharmaceuticals (EYPT) Income Statement

Compare
860 Followers

EyePoint Pharmaceuticals Income Statement

Last quarter (Q3 2024), EyePoint Pharmaceuticals's total revenue was $10.52M, a decrease of -30.77% from the same quarter last year. In Q3, EyePoint Pharmaceuticals's net income was $-29.36M. See EyePoint Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 46.02M$ 41.40M$ 36.94M$ 34.44M$ 20.36M
Gross Profit
$ 41.39M$ 33.08M$ 28.76M$ 28.61M$ 17.68M
Operating Expenses
$ 115.05M$ 112.02M$ 84.04M$ 65.90M$ 65.54M
Depreciation and Amortization
$ 464.00K$ 2.45M$ 2.77M$ 2.65M$ 2.60M
EBITDA
$ -69.00M$ -96.62M$ -50.15M$ -35.49M$ -48.01M
Operating Income
$ -75.07M$ -78.94M$ -55.28M$ -37.29M$ -47.86M
Other Income/Expenses
$ 4.36M$ -2.62M$ -3.14M$ -8.10M$ -8.93M
Pretax Income
$ -70.71M$ -102.25M$ -58.42M$ -45.39M$ -56.79M
Net Income
$ -70.80M$ -124.51M$ -63.91M$ -52.65M$ -62.97M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.82$ -3.34$ -2.22$ -4.10$ -6.04
Diluted EPS
$ -1.82$ -3.34$ -2.22$ -4.10$ -6.04
Weighted Average Shares Outstanding
38.90M 37.32M 28.76M 12.84M 10.43M
Weighted Average Shares Outstanding (Diluted)
38.90M 37.32M 28.76M 12.84M 10.43M
Currency in USD

EyePoint Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis